Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT00988208

Public ClinicalTrials.gov record NCT00988208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone With or Without Lenalidomide in Subjects With Castrate-Resistant Prostate Cancer (CRPC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with metastatic Castrate-Resistant Prostate Cancer. The addition of lenalidomide to docetaxel and prednisone is proposed to increase the life expectancy of these subjects.

Study identification

NCT ID
NCT00988208
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
1,059 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2009 (Actual)
Primary completion
Jan 13, 2012 (Actual)
Completion
Nov 28, 2016 (Actual)
Last update posted
Apr 4, 2018

2009 – 2016

United States locations

U.S. sites
66
U.S. states
24
U.S. cities
64
Facility City State ZIP Site status
Hematology Oncology Associates Phoenix Arizona 85012 —
Northern AZ Hematology and Oncology Assoc Sedona Arizona 86336 —
Arizona Oncology Tucson Arizona 85710 —
City of Hope Cancer Center Duarte California 91010-3000 —
Southwest Cancer Center - Escondido Escondido California 92025 —
Scripps Cancer Center - Clinical Research La Jolla California 92037 —
VA Long Beach Healthcare System Long Beach California 90822 —
The Angeles Clinc and Research Institute Los Angeles California 90025 —
University of Southern California Los Angeles California 90033 —
Prostate Oncology Specialists Marina del Rey California 90292 —
Stanford University Medical Center Stanford California 94035-5821 —
Rocky Mountain Cancer Centers-Colorado Springs Circle Colorado Springs Colorado 80909 —
Washington Cancer Institute Washington D.C. District of Columbia 20010 —
Melbourne Internal Medicine Associates Melbourne Florida 32901 —
Advanced Medical Specialties Miami Florida 33176 —
Florida Cancer Institute - New Hope New Port Richey Florida 34655 —
Ocala Oncology Center Ocala Florida 34474 —
Cancer Centers of Florida, P.A.- West Gore Street Orlando Florida 32806 —
South Florida Oncology - Hematology Tamarac Florida 33321 —
Palm Beach Cancer Institute, LLC West Palm Beach Florida 33401 —
Cancer Care and Hematology Specialists of Chicagoland Niles Illinois 60714 —
Lutheran General Hospital Park Ridge Illinois 60068 —
Indiana University Health Indianapolis Indiana 46219 —
Hematology and Oncology Specialist, LLC Metairie Louisiana 70006 —
Maryland Oncology Hematology PA Columbia Maryland 21044 —
Minnesota Oncology Hematology, PA Minneapolis Minnesota 55404 —
Missouri Cancer Associates Columbia Missouri 65201 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Summit Medical Group Overlook Oncology Center Berkeley Heights New Jersey 07922 —
Hematology-Oncology Associates of NNJ, P Morristown New Jersey 07960 —
Hematology Oncology Associates of South Jersey Mount Holly New Jersey 08060 —
New York Oncology Hematology P.C. Albany New York 12208 —
Columbia Univ Medical Center New York New York 10032 —
Weill Cornell Medical College Dr. Feldman's Office New York New York 10065 —
New Bern Cancer Care New Bern North Carolina 28562 —
Cancer Centers of North Carolina Raleigh North Carolina 27607 —
Mid Dakota Clinic, PC Bismarck North Dakota 58501 —
Oncology Hematology Care, Inc. Cincinnati Ohio 45242 —
Northwest Cancer Specialists-Tualatin Tualatin Oregon 97062 —
Ralph H. Johnson VA Medical Center Charleston South Carolina 29401 —
South Carolina Oncology Associates, PA Columbia South Carolina 29210 —
Cancer Center of the Carolinas Greer South Carolina 29650 —
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404 —
Cookeville Regional Medical Center Cookeville Tennessee 38501 —
Sarah Cannon Research Institute UK Nashville Tennessee 37203-1632 —
Texas Oncology, P.A.-Amarillo Amarillo Texas 79106 —
Texas Oncology-Arlington South Arlington Texas 76014 —
Texas Oncology, PA Austin Texas 78758 —
Baylor Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology, P.A.-Fort Worth Fort Worth Texas 76104 —
Longview Cancer Center Longview Texas 75601 —
Allison Cancer Center Midland Texas 79701 —
Texas Oncology, P.A. - Paris Paris Texas 75460 —
Southlake Oncology Southlake Texas 76092 —
Texas Oncology, P.A. - Tyler Tyler Texas 75702 —
Texas Oncology Deke Slayton Cancer Center Webster Texas 77598 —
Texas Oncology-Texoma Cancer Center Wichita Falls Texas 76310 —
Veterans Education and Research Association of Northern New England, Inc. White River Junction Vermont 05009 —
Cancer Outreach Associates Abingdon Virginia 24211 —
Fairfax Northern Virginia Hematology Oncology Fairfax Virginia 22031 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Cancer Institute Richmond Virginia 23230 —
Oncology and Hematology Associates of Southwest Virginia, Inc. Roanoke Virginia 24014 —
Columbia Basin Hematology and Oncology Kennewick Washington 99336 —
VA Puget Sound HCS Seattle Division Seattle Washington 98108-1532 —
Evergreen Hematology and Oncology Spokane Washington 99218 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 144 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00988208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2018 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00988208 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →